BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 38170288)

  • 1. CD38 gene polymorphism rs1130169 contribution to the increased gene expression and risk of colorectal cancer (pilot study).
    Novikov DV; Perenkov AD; Shumilova SV; Kubysheva NI; Novikov VV
    Mol Biol Rep; 2024 Jan; 51(1):63. PubMed ID: 38170288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transforming growth factor-β1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    Stanilova S; Stanilov N; Julianov A; Manolova I; Miteva L
    PLoS One; 2018; 13(8):e0201775. PubMed ID: 30071009
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TLR2 and TLR4 polymorphisms influence mRNA and protein expression in colorectal cancer.
    Proença MA; de Oliveira JG; Cadamuro AC; Succi M; Netinho JG; Goloni-Bertolo EM; Pavarino ÉC; Silva AE
    World J Gastroenterol; 2015 Jul; 21(25):7730-41. PubMed ID: 26167073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-binding site polymorphisms in genes involved in colorectal cancer etiopathogenesis and their impact on disease prognosis.
    Schneiderova M; Naccarati A; Pardini B; Rosa F; Gaetano CD; Jiraskova K; Opattova A; Levy M; Veskrna K; Veskrnova V; Buchler T; Landi S; Vodicka P; Vymetalkova V
    Mutagenesis; 2017 Oct; 32(5):533-542. PubMed ID: 29048575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphisms of caspase 8 and caspase 9 gene and colorectal cancer susceptibility and prognosis.
    Theodoropoulos GE; Gazouli M; Vaiopoulou A; Leandrou M; Nikouli S; Vassou E; Kouraklis G; Nikiteas N
    Int J Colorectal Dis; 2011 Sep; 26(9):1113-8. PubMed ID: 21538054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Heterogeneous expression of CD38 gene in tumor tissue in patients with colorectal cancer].
    Perenkov AD; Novikov DV; Sakharnov NA; Aliasova AV; Utkin OV; Baryshnikov AIu; Novikov VV
    Mol Biol (Mosk); 2012; 46(5):786-91. PubMed ID: 23156678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of the p53 codon 72 polymorphism with clinicopathological characteristics of colorectal cancer through mRNA analysis.
    De Oliveira LP; López I; Dos Santos EM; Tucci P; Marín M; Soares FA; Rossi BM; Coudry Rde A
    Oncol Rep; 2014 Mar; 31(3):1396-406. PubMed ID: 24366026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal PTGS2 mRNA levels, PTGS2 gene polymorphisms, and colorectal carcinogenesis.
    Vogel LK; Sæbø M; Høyer H; Kopp TI; Vogel U; Godiksen S; Frenzel FB; Hamfjord J; Bowitz-Lothe IM; Johnson E; Kure EH; Andersen V
    PLoS One; 2014; 9(8):e105254. PubMed ID: 25166592
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strong association of tissue inhibitor of metalloproteinase (TIMP)-2 and -3 promoter single nucleotide polymorphisms with risk of colorectal cancer in ethnic Kashmiri population - a case control study.
    Banday MZ; Sameer AS
    Biosci Rep; 2019 May; 39(5):. PubMed ID: 30988064
    [No Abstract]   [Full Text] [Related]  

  • 10. Association of the clock genes polymorphisms with colorectal cancer susceptibility.
    Karantanos T; Theodoropoulos G; Gazouli M; Vaiopoulou A; Karantanou C; Stravopodis DJ; Bramis K; Lymperi M; Pektasidis D
    J Surg Oncol; 2013 Dec; 108(8):563-7. PubMed ID: 24037774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low ABCB1 gene expression is an early event in colorectal carcinogenesis.
    Andersen V; Vogel U; Godiksen S; Frenzel FB; Sæbø M; Hamfjord J; Kure E; Vogel LK
    PLoS One; 2013; 8(8):e72119. PubMed ID: 23977225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of -1082A/G polymorphism of IL10 gene for progression of colorectal cancer and IL-10 expression.
    Miteva LD; Stanilov NS; Deliysky TS; Stanilova SA
    Tumour Biol; 2014 Dec; 35(12):12655-64. PubMed ID: 25209180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contribution of Genetic Polymorphisms of Inflammation Response Genes on Sporadic Colorectal Cancer Predisposition Risk in Malaysian Patients - A Case Control Study.
    Ankathil R; Mustapha MA; Abdul Aziz AA; Mohd Shahpudin SN; Zakaria AD; Abu Hassan MR; Musa KI
    Asian Pac J Cancer Prev; 2019 Jun; 20(6):1621-1632. PubMed ID: 31244280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic Polymorphisms in APC, DVL2, and AXIN1 Are Associated with Susceptibility, Advanced TNM Stage or Tumor Location in Colorectal Cancer.
    Rosales-Reynoso MA; Saucedo-Sariñana AM; Contreras-Díaz KB; Márquez-González RM; Barros-Núñez P; Pineda-Razo TD; Marin-Contreras ME; Durán-Anguiano Ó; Gallegos-Arreola MP; Flores-Martínez SE; Sánchez-Corona J
    Tohoku J Exp Med; 2019 Nov; 249(3):173-183. PubMed ID: 31723073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation and alterations of genes involved in NFκB/TNFAIP3- and NLRP3-inflammasome signaling affect susceptibility and outcome of colorectal cancer.
    Ungerbäck J; Belenki D; Jawad ul-Hassan A; Fredrikson M; Fransén K; Elander N; Verma D; Söderkvist P
    Carcinogenesis; 2012 Nov; 33(11):2126-34. PubMed ID: 22843550
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of polymorphisms in DNA repair genes XPD, hOGG1 and XRCC4 on colorectal cancer risk in a Chinese Han Population.
    Jin D; Zhang M; Hua H
    Biosci Rep; 2019 Jan; 39(1):. PubMed ID: 30429230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interleukin-10 -592C/A, but not -1082A/G promoter single nucleotide polymorphism, is associated with a decreased risk of colorectal cancer in an ethnic Kashmiri population: a case-control study.
    Banday MZ; Sameer AS; Chowdri NA; Haq E
    Eur J Cancer Prev; 2017 Nov; 26(6):476-490. PubMed ID: 28538040
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A functional variant at miR-520a binding site in PIK3CA alters susceptibility to colorectal cancer in a Chinese Han population.
    Ding L; Jiang Z; Chen Q; Qin R; Fang Y; Li H
    Biomed Res Int; 2015; 2015():373252. PubMed ID: 25834816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.
    Karakasheva TA; Dominguez GA; Hashimoto A; Lin EW; Chiu C; Sasser K; Lee JW; Beatty GL; Gabrilovich DI; Rustgi AK
    JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survivin -31G/C promoter polymorphism and sporadic colorectal cancer.
    Gazouli M; Tzanakis N; Rallis G; Theodoropoulos G; Papaconstantinou I; Kostakis A; Anagnou NP; Nikiteas N
    Int J Colorectal Dis; 2009 Feb; 24(2):145-50. PubMed ID: 18946675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.